Jason Springs On Selling His First Startup To Roche For $425 Million And Now Bringing Targeted Therapies To Critically Ill Patients

Jason Springs is the co-founder and CEO of Endpoint Health which provides precision medicine and integrated therapies for critical care. The company has already secured $12 million in funding from investors, including Mayfield, AME Cloud Ventures, Wireframe Ventures, and Y Combinator. Prior to this, Jason Springs sold the previous company he cofounded, GeneWEAVE, to Roche in 2015 fo $425 million.
In this episode you will learn:

Jason’s approach to team building and hiring
Structuring a team to build a business that scales
Optimizing and navigating the process of selling your company
The future of personalized and precision medicine
The most valuable things to focus on in your business
This founder’s top advice for other entrepreneurs




SUBSCRIBE ON:



iTunesGoogle PlayStitcherTuneInRSSSoundCloudSpotify





For a winning deck, take a look at the pitch deck template created by Silicon Valley legend, Peter Thiel (